BARBIERI LINDA

Barbieri, L., Salvioni, L., Banfi, A., Garbujo, S., Fiandra, L., Baioni, C., et al. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. ACS APPLIED MATERIALS & INTERFACES, 17(23), 33648-33663 [10.1021/acsami.5c06626]. Dettaglio

Secchi, V., Armanni, A., Barbieri, L., Bruno, A., Colombo, A., Fumagalli, S., et al. (2025). Advanced techniques and nanotechnologies for point-of-care testing. FRONTIERS IN NANOTECHNOLOGY, 6 [10.3389/fnano.2024.1465429]. Dettaglio

Ochoa, E., Morelli, L., Salvioni, L., Giustra, M., De Santes, B., Spena, F., et al. (2024). Co-processed materials testing as excipients to produce Orally Disintegrating Tablets (ODT) using binder jet 3D-printing technology. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 194(January 2024), 85-94 [10.1016/j.ejpb.2023.11.023]. Dettaglio

Bruno, A., Tripodi, F., Armanni, A., Barbieri, L., Colombo, A., Fumagalli, S., et al. (2024). Advancements in nanosensors for detecting pathogens in healthcare environments. ENVIRONMENTAL SCIENCE. NANO, 11(11), 4449-4474 [10.1039/d4en00381k]. Dettaglio

Morelli, L., Ochoa, E., Salvioni, L., Davide Giustra, M., De Santes, B., Spena, F., et al. (2024). Microfluidic nanoparticle synthesis for oral solid dosage forms: A step toward clinical transition processes. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 652(5 March 2024) [10.1016/j.ijpharm.2024.123850]. Dettaglio